Young Adults Diagnosed with Late-Stage Colorectal Cancer at Rising Rates
Source: https://pixabay.com/en/dark-building-young-abandoned-boy-1283752/

Young Adults Diagnosed with Late-Stage Colorectal Cancer at Rising Rates

In the past, some research has suggested that earlier screening for colorectal cancer – also known as rectal or colon cancer – could be beneficial for improving patient outcomes. For…

Continue Reading Young Adults Diagnosed with Late-Stage Colorectal Cancer at Rising Rates
New Test Quickly Identifies CSF Leak
https://pixabay.com/en/technology-robot-human-hand-2025795/

New Test Quickly Identifies CSF Leak

What do MRIs of the head and spine, CT scans of the head with contrast dye, CT myelograms of the spine, and radioisotope tests all have in common? These are…

Continue Reading New Test Quickly Identifies CSF Leak
One Family’s Story on Being Diagnosed with Progressive Familial Intrahepatic Cholangitis
Source: Pixabay.com

One Family’s Story on Being Diagnosed with Progressive Familial Intrahepatic Cholangitis

A recent article shared the story of one family’s journey with multiple family members being diagnosed with progressive familial intrahepatic cholangitis (PFIC) after years of medical issues. Progressive Familial Intrahepatic…

Continue Reading One Family’s Story on Being Diagnosed with Progressive Familial Intrahepatic Cholangitis
The National Hemophilia Foundation Is Highlighting Bleeding Disorders Awareness Month with New Campaign
source: pixabay.com

The National Hemophilia Foundation Is Highlighting Bleeding Disorders Awareness Month with New Campaign

In a recent press release, the National Hemophilia Foundation announced it has started a new campaign called “Start the Conversation” which will initiate conversations around inheritable blood disorders. Bleeding Disorders…

Continue Reading The National Hemophilia Foundation Is Highlighting Bleeding Disorders Awareness Month with New Campaign

Cutaneous T Cell Lymphoma Outcomes Improved with Investigative BV Therapy in Phase 3 Clinical Trial

A study recently published in the journal Blood Advances has demonstrated that brentuximab vedotin (BV) treatment leads to improved outcomes for primary cutaneous anapestic large-cell lymphoma (C-ALCL) and CD30-expressing mycosis fungoides (MF)…

Continue Reading Cutaneous T Cell Lymphoma Outcomes Improved with Investigative BV Therapy in Phase 3 Clinical Trial